Full Text View
Tabular View
No Study Results Posted
Related Studies
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
This study has been terminated.
( Low levels of recruitment )
Study NCT00455637   Information provided by Ipsen

First Received on April 3, 2007.   Last Updated on June 18, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebral Palsy
Additional conditions recognized in this trial
Paralysis
More general conditions related to this trial
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Botulinum type A toxin (Dysport®)
Additional drug interventions recognized in this trial
Botulinum Toxins, Type A
More general drug interventions related to this trial
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Ipsen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services